Cancer immunology: CD4+ T cells impair tumor growth through IL-3 and TNF-dependent vascular damage · Q. Lian et al.
原文开头
CD4+ T cells impair tumor growth through IL-3 and TNF-dependent vascular damage Qiaoshi Lian1†, Jia Nie2†*, Jatinder Singh3, Qiang Chen2, Jennifer Matta4, Waipan Chan1, Mariah Balmaceno-Criss2, Melanie S. Vacchio2, Weiming Yu1, Alexander D. Clark2, Elijah Edmondson4, Michael C. Kelly3, Ronald N. Germain1‡*, Rémy Bosselut2‡* Most cancer immunotherapy strategies are focused on direct tumor killing by immune cells, especially T lymphocytes. Clinical and conceptual limitations of these approaches create a need for additional strategies. We identified a tumor stroma–targeting mechanism in which tumor antigen–specific CD4+ T cells inhibit tumor growth through myeloid cell and tumor necrosis factor (TNF)–dependent vascular damage. …
摘自《科学》(Science)第392卷 第6804期 · 2026年6月18日,Q. Lian et al.。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。